Medical Foods Market

Medical Foods Market Forecasts to 2028 – Global Analysis By Product (Nutritionally Complete Formulas, Nutritionally Incomplete Formulas), Application (Cancer, Sleep Management, Neuro-Degenerative Disorders), and By Geography

4.4 (89 reviews)
Published: May 2021 ID: SMRC20550
4.4 (89 reviews)
Published: May 2021 ID: SMRC20550

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Medical Foods Market is accounted for $20.15 billion in 2020 and is expected to reach $35.14 billion by 2028 growing at a CAGR of 7.2% during the forecast period. Factors such as increasing geriatric population, rising adoption of healthy alternatives, and high expenditure in healthcare sector by governments in developed economies are driving the market growth. However, lack of awareness related to proper use of medical foods is hampering the growth of the market.

Food intended to meet nutritional requirements and/or metabolic deficiencies in an individual suffering from a particular disease is termed as medical food. It is specially formulated for a patient and is intended to be used under supervision of medical or health professionals. Medical foods offer patients an effective therapeutic tool for managing pain, sleep, and cognitive disorders without many of the risks associated with pharmaceutical drugs.

Based on the route of administration, the oral segment is going to have a lucrative growth during the forecast period which can be attributed to the high commercial viability of orally administered products as well as its ease of consumption. By geography, North America is expected to grow at a faster rate during the forecast period owing to the increasing unhealthy lifestyle among individuals in the region.

Some of the key players profiled in the Medical Foods Market include Reckitt Benckiser Group plc, Abbott Laboratories, Danone S.A., Nestlé S.A., Mead Johnson, BioMarin Pharmaceutical, Ajinomoto Cambrooke Inc, Fresenius SE & Co. KGaA, Targeted Medical Pharma Inc, Accera Inc, Alfasigma S.p.A., Metagenics Inc, Meiji Holdings and Co Ltd, Cerecin Inc, and Primus Pharmaceuticals Inc.

Routes of Administration Covered:
• Enteral
• Oral

Products Covered:
• Oral Rehydration Products
• Nutritionally Complete Formulas
• Nutritionally Incomplete Formulas   

Nutritional Ingredients Covered:
• Proteins
• Vitamins and Minerals
• Isoflavones
• Omega-3
• Phytosterols 

Forms Covered:
• Powder
• Liquid
• Tablets & Capsules
• Gels
• Bars
• Other Forms

Packagings Covered:
• Packets
• Bottle
• Can
• Jar 

Age Groups Covered:
• Adults
• Adolescent
• Weaning
• Infants

Applications Covered:
• Alzheimer’s Disease
• Cancer (Chemotherapy-Induced Diarrhea)
• Attention Deficit Hyperactivity Disorder (ADHD)
• Sleep Management
• Neuro-Degenerative Disorders
• Maple Syrup Urine Disease (MSUD)
• Diabetes (Diabetic Neuropathy)
• Depression
• Chronic Conditions
• Obesity and Hypertension
• Urea Cycle Disorders
• Inborn Errors of Metabolism
• Pathogen Related Infections
• Minimal Hepatic Encephalopathy
• Neurological & Psychological Disorders
• Nutritional Deficiency
• Ophthalmology
• Orphan Diseases
• Homocystinuria
• Organic Acidurias
• Pain Management
• Gastrointestinal Disorders
• Methylmalonic Acidemia
• Isovaleric Acidemia
• Propionic Acidemia
• Tyrosinemia Types I And II

Sales Channels Covered:
• Retail Sales
• Online Sales
• Institutional Sales (Hospital Pharmacies)

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.